Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Find various ways to make cash today that can help you earn instantly. Start implementing these methods now!
22,675 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Despite a slim yield, the WisdomTree U.S. Quality Dividend Growth Fund continues to attract institutional buyers. Her...
Bay Area housing costs are forcing retirees to rethink income strategies. This piece outlines three paths to a divide...
Rivian remains valued far below Ford despite big hype around electric-vehicle startups. With Rivian’s deliveries risi...
The chip market has cooled as investors weigh AI infrastructure costs. This piece highlights three AI chip stocks to ...
A sharp move lower in Carnival Corporation stock sank today as investors weigh macro headwinds against the cruise ope...
Investors are keen on Ingevity (NGVT) 2026 earnings as the company reports Q1 results. This article breaks down the n...
With the Fed set to act this month, a dirt-cheap stock looks attractive amid crosscurrents in the market. Here’s why ...
Investors are quietly shifting capital away from high-velocity AI bets and toward steady cash-flow leaders. Discover ...
Berkshire Hathaway is changing under Greg Abel, shifting toward concentrated bets on Apple and Alphabet. This article...
Retirees chasing amlp’s 7.9% yield face a tug-of-war between high income and the risk of payout gaps. This deep dive ...
A fintech just reported a blowout quarter, yet the stock still looks cheap to patient investors. This analysis breaks...